Counselors in Luquillo, PR Accepting Medicare

1 Counselors found. Showing 1 - 1

Mr. Darwin Morales, MSC/MFT, CPL, LSW Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: K13 Calle M, Extencion Alamar, Luquillo, PR 00773 Phone: 787-801-0217

News Archive

Phase 1 BelCHOP study shows belinostat and CHOP chemo regimen as first-line treatment for PTCL

Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations and a primary focus in Hematology and Oncology, and Onxeo S.A., an innovative company specializing in the development of orphan oncology drugs, today jointly announced the results from their Phase 1 combination trial of belinostat (Beleodaq) with the CHOP (Cyclophosphamide, Hydroxyl-doxorubicin; Vincristine, and Prednisone) chemotherapy regimen as first-line treatment for newly diagnosed peripheral T-cell lymphoma (PTCL).

IOM briefing to discuss ways to improve health care quality, address health care work force shortage

Since its inception in July 2009, the Committee on the Robert Wood Johnson Foundation Initiative on the Future of Nursing, at the Institute of Medicine has worked to develop a blueprint for using nurse-led models of innovation to improve the health care system.

Early contact with physiotherapist appears to provide superior benefits

Patients with muscle and joint pain are often at least as well served by seeing a physiotherapist as by consulting a doctor when they seek help at a primary health care centre. Over time, the health benefits of first going to a physiotherapist appear slightly superior, new research shows.

New Penumbra 3D device may effectively treat stroke

At last week's ABC-WIN Seminar, Prof. Dr. Michael Knauth, Director of Neuroradiology, University Hospital of Goettingen, Goettingen, Germany, and President-elect of the German Society of Neuroradiology, presented the European evaluation data on Separator 3D, a next-generation clot engagement device that works in conjunction with aspiration at the site of the lesion causing an acute ischemic stroke to remove the clot and restore blood flow to affected brain tissue.

Curis reports topline results from GDC-0449 Phase II clinical trial for metastatic colorectal cancer

Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced topline results from a Phase II clinical trial conducted by Roche and Genentech, Curis' collaborator and a wholly owned member of the Roche Group, of GDC-0449, a first-in-class Hedgehog pathway inhibitor. GDC-0449 was tested in combination with Avastin® (bevacizumab) and FOLFOX or FOLFIRI chemotherapy in first-line metastatic colorectal cancer patients.

Read more Medical News

› Verified 3 days ago